Dehydration linked to muscle cramps in IRONMAN triathletes
As athletes prepare to dive into Hawaiian waters for the first part of the IRONMAN World Championship on Oct. 26, they may want to pay a little extra… read more.
As athletes prepare to dive into Hawaiian waters for the first part of the IRONMAN World Championship on Oct. 26, they may want to pay a little extra… read more.
About 10% of Americans believe they are allergic to penicillin, and approximately 90% of those patients are not actually allergic. As a result, those with the penicillin allergy… read more.
Bayer and its collaboration partner Regeneron presented results from the open-label extension study of the clinical trial PHOTON in patients with diabetic macular edema (DME) at three years,… read more.
Eye care specialists could see artificial intelligence help in diagnosing infectious keratitis (IK), a leading cause of corneal blindness worldwide, as a new study finds that deep learning… read more.
A team of leading sleep researchers from the British Sleep Society have called for the government to abolish the twice-yearly clock changes in the UK due to the… read more.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Kevzara…. read more.
New data shows that the number of children suffering a seizure after swallowing medications or illegal substances has doubled between 2009 and 2023 in the US. The findings… read more.
Eli Lilly and Company announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for donanemab, an injection for intravenous infusion every four weeks… read more.
The research focuses on adapting an acceptance-based mental health intervention called Acceptance and Commitment Training (ACT-W), which was developed by Dr Paul Flaxman and Ross McIntosh at City St George’s,… read more.
Johnson & Johnson announced that 23 abstracts featuring new real-world and clinical trial data from across its neuropsychiatry portfolio and pipeline will be presented at the annual U.S…. read more.
After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy (sacituzumab goviteca-hziy) as a bladder cancer treatment in the U.S. Gilead Sciences announced… read more.
Long term exposure to arsenic in water may increase cardiovascular disease and especially heart disease risk even at exposure levels below the federal regulatory limit (10µg/L) according to… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
